Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 25% ± 8% | |
| glutamatergic neuron | 7 studies | 41% ± 24% | |
| GABAergic neuron | 6 studies | 39% ± 20% | |
| astrocyte | 6 studies | 26% ± 6% | |
| oligodendrocyte precursor cell | 6 studies | 30% ± 10% | |
| interneuron | 6 studies | 34% ± 18% | |
| microglial cell | 3 studies | 18% ± 0% | |
| epithelial cell | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 532.37 | 459 / 459 | 100% | 21.64 | 1118 / 1118 |
| brain | 100% | 525.72 | 2639 / 2642 | 100% | 19.86 | 704 / 705 |
| ovary | 100% | 457.22 | 180 / 180 | 100% | 12.61 | 428 / 430 |
| prostate | 100% | 405.91 | 245 / 245 | 99% | 11.78 | 499 / 502 |
| esophagus | 100% | 296.72 | 1441 / 1445 | 99% | 12.57 | 181 / 183 |
| thymus | 100% | 476.22 | 653 / 653 | 99% | 10.63 | 596 / 605 |
| bladder | 100% | 344.90 | 21 / 21 | 98% | 12.04 | 493 / 504 |
| lung | 98% | 260.53 | 566 / 578 | 100% | 11.47 | 1150 / 1155 |
| kidney | 100% | 382.83 | 89 / 89 | 96% | 8.40 | 868 / 901 |
| uterus | 100% | 349.34 | 170 / 170 | 96% | 10.57 | 442 / 459 |
| pancreas | 99% | 245.36 | 325 / 328 | 97% | 7.85 | 173 / 178 |
| stomach | 100% | 285.19 | 358 / 359 | 97% | 10.28 | 276 / 286 |
| intestine | 100% | 314.63 | 966 / 966 | 96% | 9.51 | 507 / 527 |
| adrenal gland | 100% | 543.33 | 258 / 258 | 92% | 8.14 | 212 / 230 |
| skin | 100% | 573.62 | 1809 / 1809 | 86% | 7.47 | 406 / 472 |
| liver | 96% | 174.06 | 217 / 226 | 81% | 4.91 | 327 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 12.77 | 29 / 29 |
| spleen | 100% | 442.87 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.78 | 1 / 1 |
| adipose | 100% | 332.40 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 242.03 | 1319 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 233.23 | 793 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 6.47 | 43 / 45 |
| heart | 93% | 178.01 | 798 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 54% | 206.12 | 500 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 54% | 3.01 | 43 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF138 |
| Protein name | Zinc finger protein 138 ZNF138 protein |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation as a repressor. |
| Accessions | E7EWC5 ENST00000440155.6 [P52744-2] ENST00000359735.7 A2RRP7 J3QSS9 ENST00000440598.2 ENST00000437743.1 ENST00000494380.5 A0A0A0MT90 C9JHF6 P52744 A0A0A0MRG3 ENST00000307355.12 |